Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (121-130 of 427) with videos related to

Pageof 43
Sort By:
Journal of Medicinal Chemistry|August 18, 2006
Replacement of the metabolically labile methyl esters in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors with isoxazolone, isoxazole, oxazolone, or cyano substituentsBo-Liang Deng, Tracy L Hartman, Robert W Buckheit, et al.
Archiv Der Pharmazie|October 8, 2005
Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analoguesGuang-Fu Sun, Yun-Yan Kuang, Fen-Er Chen, et al.
Acta Pharmaceutica Sinica. B|September 2, 2025
Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitorsXiao-Mei Chen, Qing-Qing Hao, Christophe Pannecouque, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 5, 2009
Non-nucleoside reverse transcriptase inhibitors (Part 18): synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazinesYuan-Zhen Xiong, Hai-Rong Hu, Fen-Er Chen, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 8, 2002
Synthesis and anti-hIV activity of 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2-substituted benzimidazolesAngela Rao, Alba Chimirri, Erik De Clercq, et al.
European Journal of Medicinal Chemistry|November 20, 2012
Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitorsSergio R Ribone, Volker Leen, Marcela Madrid, et al.
International Journal of Antimicrobial Agents|April 2, 2016
The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cellRosalba Perrone, Elena Butovskaya, Sara Lago, et al.
Bioorganic Chemistry|February 15, 2023
Structure-directed linker optimization of novel HEPTs as non-nucleoside inhibitors of HIV-1 reverse transcriptaseQing-Qing Hao, Xiao-Mei Chen, Christophe Pannecouque, et al.
Bioorganic Chemistry|October 22, 2023
4-Phenylcoumarin derivatives as new HIV-1 NNRTIs: Design, synthesis, biological activities, and computational studiesRasha Z Batran, Ahmed Sabt, Mohammed A Khedr, et al.
Chemical Biology & Drug Design|April 11, 2016
Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones as HIV-1 non-nucleoside reverse-transcriptase inhibitorsWenxin Li, Boshi Huang, Dongwei Kang, et al.
Pageof 43

Showing results (121-130 of 427) with videos related to

Sort By:
Pageof 43
Journal of Medicinal Chemistry|August 18, 2006
Replacement of the metabolically labile methyl esters in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors with isoxazolone, isoxazole, oxazolone, or cyano substituentsBo-Liang Deng, Tracy L Hartman, Robert W Buckheit, et al.
Archiv Der Pharmazie|October 8, 2005
Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analoguesGuang-Fu Sun, Yun-Yan Kuang, Fen-Er Chen, et al.
Acta Pharmaceutica Sinica. B|September 2, 2025
Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitorsXiao-Mei Chen, Qing-Qing Hao, Christophe Pannecouque, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 5, 2009
Non-nucleoside reverse transcriptase inhibitors (Part 18): synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazinesYuan-Zhen Xiong, Hai-Rong Hu, Fen-Er Chen, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 8, 2002
Synthesis and anti-hIV activity of 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2-substituted benzimidazolesAngela Rao, Alba Chimirri, Erik De Clercq, et al.
European Journal of Medicinal Chemistry|November 20, 2012
Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitorsSergio R Ribone, Volker Leen, Marcela Madrid, et al.
International Journal of Antimicrobial Agents|April 2, 2016
The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cellRosalba Perrone, Elena Butovskaya, Sara Lago, et al.
Bioorganic Chemistry|February 15, 2023
Structure-directed linker optimization of novel HEPTs as non-nucleoside inhibitors of HIV-1 reverse transcriptaseQing-Qing Hao, Xiao-Mei Chen, Christophe Pannecouque, et al.
Bioorganic Chemistry|October 22, 2023
4-Phenylcoumarin derivatives as new HIV-1 NNRTIs: Design, synthesis, biological activities, and computational studiesRasha Z Batran, Ahmed Sabt, Mohammed A Khedr, et al.
Chemical Biology & Drug Design|April 11, 2016
Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones as HIV-1 non-nucleoside reverse-transcriptase inhibitorsWenxin Li, Boshi Huang, Dongwei Kang, et al.
Pageof 43